Skip to main content

Nasdaq Markets

Bristol-Myers: FDA To Review BLA For Liso-cel - Quick Facts

6 years 7 months ago
(RTTNews) - Bristol-Myers Squibb Company (BMY) announced the U.S. FDA has accepted for Priority Review its Biologics License Application for lisocabtagene maraleucel, or liso-cel, for adult patients with Relapsed or Refractory Large B-Cell Lymphoma. Liso-cel is an investigationa
RTTNews

Will Warren Buffett Save Seritage or Push It Under?

6 years 7 months ago
The story at Seritage Growth Properties (NYSE: SRG) is still the same as it was when the company was spun off from now bankrupt Sears Holdings in 2015. It is the timing of management's action plan that's gotten all screwed up. It prepared as best it could, but at this point it i
The Motley Fool
Checked
18 minutes 14 seconds ago
This feed is responsible for generating the rss feed related to the topic Markets
Subscribe to Nasdaq Markets feed